Skip to main content
logo
Q-Line Biotech Limited (NSE:QLINE)
India flag India · Delayed Price · Currency is INR
528.30
-8.65 (-1.61%)
At close: Aug 27, 2026

Q-Line Biotech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
3,4743,4743,1382,0361,8273,042
Revenue Growth
14.22%10.73%54.08%11.44%-39.92%77.46%
Gross Profit
2,1332,1331,6591,099940.731,565
Operating Income
929.58929.58738.57347.27327.5733.32
Net Income
557.22557.22450.96344.49320.97550.16
Earnings Per Share
34.7934.7928.6321.8720.3836.68
EPS Growth
-5.15%21.51%30.91%7.33%-44.44%299.62%

Revenue by Segment
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Manufacturing
2,3022,3021,690700.54508.72
Trading
1,1151,1151,4481,3361,319
Total
3,4173,4173,1382,0361,827

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
764.37764.37470.26299.56900.19541.1
Total Debt
2,2552,2551,663969.1736.48434.32
Net Cash (Debt)
-1,490-1,490-1,193-669.54163.71106.78
Net Cash Growth
----53.31%-
Net Cash Per Share
-93.06-93.06-75.73-42.5110.397.12

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
163.76163.76-13.22-241.79249.69-
Capital Expenditures
-359.14-359.14-562.58-489.01-262.67-
Free Cash Flow
-195.38-195.38-575.8-730.8-12.98-
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
61.40%61.40%52.86%53.96%51.48%51.46%
Operating Margin
26.76%26.76%23.54%17.05%17.92%24.11%
Pretax Margin
20.88%20.88%15.24%21.31%22.19%23.43%
Profit Margin
16.04%16.04%14.37%16.92%17.57%18.09%
FCF Margin
-5.62%-5.62%-18.35%-35.89%-0.71%-